Garg Vipin K 4
4 · Altimmune, Inc. · Filed Feb 2, 2026
Research Summary
AI-generated summary of this filing
Altimmune (ALT) Director Vipin K. Garg Exercises RSUs and Buys Shares
What Happened
Vipin K. Garg, a director of Altimmune, had 26,775 restricted stock units (RSUs) convert into common shares on 2026-01-30 (exercise/conversion at $0.00). To satisfy tax withholding, 11,632 of those shares were surrendered to the company (reported as disposed) for a value of $65,139 ($5.60 per share). On 2026-01-31 he also acquired 6,926 shares under the company’s Employee Stock Purchase Plan (ESPP) at $3.07 per share for $21,263. Net new shares received from these events = 22,069 (15,143 net from RSU vesting + 6,926 ESPP).
Key Details
- Transaction dates: RSU conversion and tax withholding on 2026-01-30; ESPP purchase on 2026-01-31. Filing date: 2026-02-02 (timely).
- Prices/values: RSU conversion recorded at $0.00 (no exercise cash paid); 11,632 shares withheld at $5.60 = $65,139; ESPP purchase 6,926 shares @ $3.07 = $21,263.
- Shares owned after transaction: total holdings not disclosed in the provided excerpt; net shares received from these events = 22,069.
- Footnotes of note: F1–F2 explain RSUs are contingent rights to shares and that shares were surrendered solely to cover taxes; F3–F4 state the ESPP purchase covers the Aug 1, 2025–Jan 31, 2026 period and was priced at 85% of the Aug 1, 2025 closing price; F5 describes the RSU vesting schedule (4 annual installments beginning Jan 30, 2023).
- Transaction codes: M = exercise/conversion of derivative (RSU vesting), F = tax withholding (shares surrendered), A = award/ESPP acquisition.
Context
- This appears to be routine RSU vesting with shares withheld to cover tax obligations (a cashless withholding), plus a regular ESPP purchase — not an open-market sale that would necessarily signal a change in insider sentiment.
- The RSU conversion at $0.00 reflects vesting/settlement of restricted units rather than payment to exercise options.
- No indication from this filing of a 10% owner transaction or a 10b5-1 plan.
Insider Transaction Report
Form 4Exit
Garg Vipin K
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.0001
[F1]2026-01-30+26,775→ 429,225 total - Tax Payment
Common Stock, par value $0.0001
[F2]2026-01-30$5.60/sh−11,632$65,139→ 417,593 total - Award
Common Stock, par value $0.0001
[F3][F4]2026-01-31$3.07/sh+6,926$21,263→ 424,519 total - Exercise/Conversion
Restricted Stock Units
[F1][F5]2026-01-30−26,775→ 26,775 total→ Common Stock, par value $0.0001 (26,775 underlying)
Footnotes (5)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
- [F2]Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
- [F3]These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2025 through January 31, 2026
- [F4]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2025
- [F5]The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
Signature
/s/ Gregory Weaver, as Attorney-in-Fact|2026-02-02